🟢 20/20 Biolabs is trading 9.7% up in pre-market

20/20 Biolabs is trading at $0.38, up 9.66% in pre-market; the move’s cause remains unclear.

• No clear company-specific catalyst was identified for the October 8 pre-market move.
• The October 7 investor webinar was announced in advance; available listings show a replay but no new October 8 announcement or explanation for the move.
• Broader markets and futures are lower, so the supplied market context does not explain the stock’s rise.